Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma

Fig. 6

Evaluation of immunotherapy sensitivity between these two stemness subtypes in TCGA-LUSC dataset. A Expression profile of the expression of representative immune checkpoint genes between stemness subtype A and B groups. B The relative probabilities to respond to PD-1 and CTLA-4 inhibitors in stemness subtype A and B groups. C The TIDE, T cell dysfunction and MSI scores in stemness subtype A and B groups. * p < 0.05, *** p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us